InVitae (NYSE: NVTA) and Natera (NASDAQ:NTRA) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their profitability, dividends, analyst recommendations, institutional ownership, valuation, risk and earnings.
Risk and Volatility
Get InVitae alerts:
InVitae has a beta of 1.2, indicating that its stock price is 20% more volatile than the S&P 500. Comparatively, Natera has a beta of 2.07, indicating that its stock price is 107% more volatile than the S&P 500.
....More>>>